pt141 results Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction Evaluation of the safety, pharmacokinetics

Fine vellus hairs in thinning areas become visible at 6 to 12 weeks

This procedure involves inserting a small catheter through a needle into the epidural space or directly next to affected nerves

Smart search bars, personalized lobbies, and curated recommendation rows make it easy to spot high-return titles or newly launched themes

As of mid-2024, a full 6% of US adults are actively taking GLP-1 agonists , but the huge potential addressable market for these drugs, combined with an ongoing shortage, means that these medications have plenty of additional potential running room

Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs